People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biosortia Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $10.1M | $25.7M | 2011 |
| EnvyPak, Inc. | — | Other | Pre-Seed | $100K | $2.3M | 2016 |
Ross O Youngs at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ross O Youngs on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roger A. Vaughan | 1 | 1 |
| Kurt D. Dieck | 1 | 1 |
| Henry J. Cialone | 1 | 1 |
| Derrell J. Porter | 1 | 1 |
| Robert D. Kamerschen | 1 | 1 |
| Derrell O Porter | 1 | 1 |
| Henry O Cialone | 1 | 1 |
| Robert O Kamerschen | 1 | 1 |
| Douglas L. Poling | 1 | 1 |
| Ron O Moss | 1 | 1 |
| Derrell L. Porter | 1 | 1 |
| Douglas O Poling | 1 | 1 |
| John O Ryals | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.